11,626
Views
2
CrossRef citations to date
0
Altmetric
Biochemistry, Cell and Molecular Biology

Pharmacological profile of Shiva Gutika: an uncharted and versatilepolyherbal drug

, , &
Pages 215-219 | Received 25 Nov 2020, Accepted 10 Mar 2021, Published online: 25 Mar 2021

References

  • Altemimi A, Lakhssassi N, Baharlouei A, Watson DG, Lightfoot DA. 2017. Phytochemicals: extraction, isolation, and identification of bioactive compounds from plant extracts. Plants. 6:42.
  • Anil LA, Acharya GS. 2013. A comparative clinical study to evaluate the therapeutic effect of Shiva Gutika in patients with H. I.V Infection. Anc Sci Life. 32:S30.
  • Anquez-Traxler C. 2011. The legal and regulatory framework of herbal medicinal products in the European Union: a focus on the traditional herbal medicines category. Drug Inf J. 45:15–23.
  • Bhope SG, Nagore DH, Kuber VV, Gupta PK, Patil MJ. 2011. Design and development of a stable polyherbal formulation based on the results of compatibility studies. Pharmaco Res. 3:122–129.
  • Chauhan A, Semwal DK, Mishra SP, Semwal RB. 2017. Ayurvedic concept of shatkriyakala: a traditional knowledge of cancer pathogenesis and therapy. J Integr Med. 15:88–94.
  • Deshmukh V, Kulkarni A, Bhargava S, Patil T, Ramdasi V, Gangal S, Godse V, Datar S, Gujar S, Sardeshmukh S. 2014. Effectiveness of combinations of Ayurvedic drugs in alleviating drug toxicity and improving quality of life of cancer patients treated with chemotherapy. Support Care Cancer. 22:3007–3015.
  • Dinesh C, Dixit SK, Sen PC, Joshi D. 1988. An experimental study of kutajarishta with special reference to amoebiasis. Anc Sci Life. 8:100–102.
  • Gedeon AK, Tiller GE, Le Merrer M, Heuertz S, Tranebjaerg L, Chitayat D, et al. 2001. The molecular basis of X-linked spondyloepiphyseal dysplasia tarda. Am J Hum Genet. 68:1386–1397.
  • Hassannia B, Logie E, Vandenabeele P, Vanden Berghe T, Vanden Berghe W. 2020. Withaferin A: from ayurvedic folk medicine to preclinical anti-cancer drug. Biochem Pharmacol. 173:113602.
  • Hegde G, Sanjay KMD, Cutinha CT. 2018. Single blind randomized controlled clinical study to evaluate the efficacy and safety of Shiva Gutika in dyslipidaemia. Int Ayur Med J. 6:1256–1263.
  • Karimi A, Majlesi M. 2015. Rafieian–Kopaei M. herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 4:27–30.
  • Mahesh TS, Shreevidya M. 2014. A review on balya action mentioned in ayurveda. J Ayurveda Integr Med. 5:80–84.
  • Mishra AK. 2018. Shiva Gutika – A critical approach to its pharmacological action. Int J Curr Med Pharma Res. 4:3195–3197.
  • Parasuraman S, Thing GS, Dhanaraj SA. 2014. Polyherbal formulation: concept of ayurveda. Pharmacogn Rev. 8:73–80.
  • Patel SS, Shah RS, Goyal RK. 2009. Antihyperglycemic, antihyperlipidemic and antioxidant effects of dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats. Indian J Exp Biol. 47:564–570.
  • Sharma H. 2016. Ayurveda: Science of life, genetics, and epigenetics. Ayu. 37:87.
  • Shilpa S, Venkatesha MCG. 2011. Understanding personality from Ayurvedic perspective for psychological assessment: A case. Ayu. 32(1):12–19.
  • Singh SK, Rajoria K. 2016. Ayurvedic management of spondyloepiphyseal dysplasia tarda, a rare hereditary disorder. J Ayurveda Integr Med. 7:249–254.
  • Sumanth M, Swetha S. 2012. Elucidation of mechanism of anti-arthritic action of arthosansar-a polyherbal formulation. Indian J Tradit Knowl. 11:704–713.
  • Veeresham C. 2012. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 3:200–201.
  • Vishwesh BN, Bhat SK. 2014. A clinical study to evaluate the role of Shiva Gutika in pelvic inflammatory disease. J Ayurveda Hol Med. 2:27–32.